448 related articles for article (PubMed ID: 31734731)
1. Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.
Procianoy EDFA; de Abreu E Silva FA; Maróstica PJC; Quinton PM
Lung; 2020 Feb; 198(1):151-156. PubMed ID: 31734731
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
4. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
Andersson C; Dragomir A; Hjelte L; Roomans GM
Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
[TBL] [Abstract][Full Text] [Related]
6. Correlating genotype with phenotype using CFTR-mediated whole-cell Cl
Noel S; Servel N; Hatton A; Golec A; Rodrat M; Ng DRS; Li H; Pranke I; Hinzpeter A; Edelman A; Sheppard DN; Sermet-Gaudelus I
J Physiol; 2022 Mar; 600(6):1515-1531. PubMed ID: 34761808
[TBL] [Abstract][Full Text] [Related]
7. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
[TBL] [Abstract][Full Text] [Related]
8. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis.
Ho LP; Samways JM; Porteous DJ; Dorin JR; Carothers A; Greening AP; Innes JA
Eur Respir J; 1997 Sep; 10(9):2018-22. PubMed ID: 9311495
[TBL] [Abstract][Full Text] [Related]
9. Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.
Walker LC; Venglarik CJ; Aubin G; Weatherly MR; McCarty NA; Lesnick B; Ruiz F; Clancy JP; Sorscher EJ
Am J Respir Crit Care Med; 1997 May; 155(5):1684-9. PubMed ID: 9154877
[TBL] [Abstract][Full Text] [Related]
10. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.
Fajac I; Hubert D; Guillemot D; Honoré I; Bienvenu T; Volter F; Dall'Ava-Santucci J; Dusser DJ
Thorax; 2004 Nov; 59(11):971-6. PubMed ID: 15516474
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
12. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
[TBL] [Abstract][Full Text] [Related]
13. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
14. Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia.
Cho DY; Zhang S; Skinner DF; Lim DJ; Banks C; Grayson JW; Tearney GJ; Rowe SM; Woodworth BA
Int Forum Allergy Rhinol; 2022 May; 12(5):690-698. PubMed ID: 34704673
[TBL] [Abstract][Full Text] [Related]
15. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
17. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
[TBL] [Abstract][Full Text] [Related]
18. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
[TBL] [Abstract][Full Text] [Related]
19. CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
Hirtz S; Gonska T; Seydewitz HH; Thomas J; Greiner P; Kuehr J; Brandis M; Eichler I; Rocha H; Lopes AI; Barreto C; Ramalho A; Amaral MD; Kunzelmann K; Mall M
Gastroenterology; 2004 Oct; 127(4):1085-95. PubMed ID: 15480987
[TBL] [Abstract][Full Text] [Related]
20. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
